Generic drug manufacturers Heritage Pharmaceuticals and Apotex have agreed to pay $49.1 million to settle allegations from nearly all US states that the companies inflated and manipulated ...
READ MOREValneva is eyeing a 2027 launch for its Pfizer-partnered Lyme disease vaccine, CEO Thomas Lingelbach said Thursday during the company’s investor day.
READ MOREFor the second time in five years, an FDA advisory committee voted against endorsing the benefit-risk profile of Lexicon's drug sotagliflozin.
READ MOREBaxter has “suspended commercial activities” of its intravenous products in China to ease supply issues in the US caused by Hurricane Helene, the company told Endpoints News.
READ MORE